Aug 2026· MedComm· Vol 7· 0 citations· 235 references
Medicine
TL;DR
This paper systematically summarizes the molecular mechanisms by which mitochondria mediate apoptosis and provides an in‐depth analysis of intrinsic factors, including mitochondrial structural remodeling, dynamics imbalance, dynamics imbalance, and mitochondrial DNA abnormalities.
Abstract
Apoptosis is a core program regulating organismal homeostasis and plays a pivotal role in the onset and progression of most diseases. Increasing evidence in recent years indicates that mitochondria are not only central to cellular metabolism but also play a pivotal role in regulating apoptosis. However, no systematic review elucidating how mitochondria finely regulate apoptotic processes through multidimensional mechanisms, including apoptosis‐resistant diseases such as cancer. This paper systematically summarizes the molecular mechanisms by which mitochondria mediate apoptosis. We focus on the regulation of cytochrome c (Cyt c) release by the Bcl‐2 protein family and the activation of downstream caspase cascades. Furthermore, we provide an in‐depth analysis of intrinsic factors, including mitochondrial structural remodeling (membrane rupture, cristae remodeling, and membrane lipid redistribution), dynamics imbalance (fusion, fission, and mitophagy), and mitochondrial DNA abnormalities, as well as extrinsic factors involving interorganelle interactions with the endoplasmic reticulum, lysosomes, and other organelles. Additionally, we review clinical and preclinical advances in drugs targeting these pathways. This review aims to provide a comprehensive perspective on the complex network of mitochondrial regulation of apoptosis and offer valuable insights for developing novel clinical therapeutic strategies for cancer and other diseases.
Overall, these findings establish HSP47 as a novel regulator of mtROS generation, suggesting that the HSP47–mtROS axis represents a promising therapeutic target for oxidative stress-related disorders and a potential role for exploring virus-induced cellular responses in future research.
S. Surinkaew, N. Hosoya, Hiromu Ito et al.· Cells· 0 citations
Current understanding of how dysregulation of selective autophagy promotes the accumulation of damaged mitochondria, oxidative stress, inflammation, and cell death in mitochondrial diseases is systematised.
E. D. Avdonina, Sergey I. Kutsev, A. Shestopalov· Cells· 1 citation
This review summarizes the major sources and regulation of mtROS, their involvement in cancer-associated signaling pathways, mitochondrial calcium dynamics, metabolic adaptations, and resistance to anticancer therapies, and discusses current and emerging mitochondrial- targeting strategies aimed at exploiting mtROS sig...
B. Velmurugan, Shu-Hui Lin, Chih-Yang Huang et al.· Oncology Research· 0 citations
The structural composition, physiological functions, and mechanism of action of MAMs in diseases are reviewed, focusing on the regulatory effects of key resident proteins and potential therapeutic targets, and the current research bottlenecks and future development directions are discussed.
Mian-Li Bian· Global Journal of Pharmacy &...· 0 citations
More research in the field may unravel the mechanistic details of the organellar crosstalk that works in concert with classical aging pathways to sustain aging progression, which may help promote healthier aging.
Recent studies demonstrate promising therapeutic targets for mitochondrial dysfunction and highlight the need for research in mitochondrial function to change the therapeutic landscape in the management of mitochondrial dysfunction-associated diseases.
Olufemi Akintayo Akinkunmi, Feyikemi Funmilayo Araba, J. A. Chukwudebelu et al.· Frontiers in Cell and Develo...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.